BioNote, Inc. (KRX:377740)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,100.00
+20.00 (0.39%)
Last updated: Jun 5, 2025
23.79%
Market Cap 516.94B
Revenue (ttm) 105.92B
Net Income (ttm) 42.38B
Shares Out 101.36M
EPS (ttm) 416.76
PE Ratio 12.24
Forward PE n/a
Dividend 200.00 (3.92%)
Ex-Dividend Date Mar 28, 2025
Volume 64,756
Average Volume 92,774
Open 5,120.00
Previous Close 5,080.00
Day's Range 5,050.00 - 5,180.00
52-Week Range 3,990.00 - 6,400.00
Beta 1.11
RSI 70.13
Earnings Date May 15, 2025

About BioNote

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwa... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 298
Stock Exchange Korea Stock Exchange
Ticker Symbol 377740
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.